Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

357 results about "Cyclopentanes" patented technology

A group of alicyclic hydrocarbons with the general formula R-C5H9.

Cyclopentane derivative-containing inhibitor as well as preparation method and application thereof

The invention relates to an inhibitor containing cyclopentane derivatives as well as a preparation method and application of the inhibitor. Particularly, the invention relates to a compound shown in a general formula (I), a preparation method of the compound, a pharmaceutical composition containing the compound and application of the compound as an inhibitor in treatment of cardiovascular diseases, cerebrovascular diseases and other diseases, and substituents in the general formula (I) are as defined in the specification. # imgabs0 #
Owner:SHANGHAI HANSOH BIOMEDICAL CO LTD +1

Crystal form of heterocyclic compound and pharmaceutical composition thereof

The invention belongs to the field of medical chemistry, and particularly relates to a crystal form of a heterocyclic compound and a pharmaceutical composition thereof. Specifically, the invention relates to a crystal form of 4-((2R, 3S, 5R)-3-(3, 4-difluoro-2-methoxyphenyl)-5-methyl-5-(trifluoromethyl) thiacyclopentane-2-formamido) pyridine-2-formamide and a pharmaceutical composition of the crystal form of 4-((2R, 3S, 5R)-3-(3, 4-difluoro-2-methoxyphenyl)-5-methyl-5-(trifluoromethyl) thiacyclopentane-2-formamido) pyridine-2-formamide. The crystal form is good in crystallinity, excellent in chemical stability and crystal form stability, high in process safety and capable of playing a good drug effect in various animal models.
Owner:SICHUAN KELUN PHARMA RES INST CO LTD

Refining device and refining method of polymerization product and application

The invention discloses a refining device and method for a polymerization product and application. The refining device comprises an aldehyde removal tower, a dehydration tower, a water separation tank, a light component removal tower, a byproduct tower and a product tower. According to the present invention, the reaction product obtained through the ethylene glycol dehydration condensation reaction contains water, acetaldehyde, diethylene glycol, 1, 4-dioxane, 2-methyldioxocyclopentane and other components, and has characteristics of complex components and coexistence of multiple azeotropic pairs, and the invention provides the sequential rectification method by introducing the azeotropic breaking component according to the composition, therefore, a diethylene glycol product with high purity and byproducts of acetaldehyde and 1, 4-dioxane are separated, the process is continuous and easy to operate, and the method has industrial feasibility.
Owner:DALIAN INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES

Cyclopentane-based heat exchanger

The invention discloses a heat exchanger based on cyclopentane, and relates to the technical field related to heat exchangers. The heat exchanger comprises a heat exchanger body, fixing discs are arranged at the two ends in the heat exchanger body, a cleaning mechanism is arranged in the heat exchanger body and comprises heat exchange pipes arranged on the fixing discs, the heat exchange pipes are slidably connected to an upper baffle and a lower baffle, and the upper baffle and the lower baffle are provided with a first threaded rod and a second threaded rod correspondingly; a first cylinder cover is arranged at one end of the heat exchanger body and internally provided with a cooling chamber. By rotating the first threaded rod and the second threaded rod, the upper baffle and the lower baffle can be driven to scrape the inner wall of the heat exchanger body and the outer wall of the heat exchange pipe, dirt accumulated on the inner wall of the heat exchanger body and the outer wall of the heat exchange pipe is scraped away, and the dirt is prevented from adhering to the inner wall of the heat exchanger body and the outer wall of the heat exchange pipe; and the heat utilization rate of the heat exchanger main body is seriously influenced.
Owner:GUANGDONG UNIV OF PETROCHEMICAL TECH +1

Adamantane derivative as well as synthesis method and application thereof

The invention belongs to the technical field of drug synthesis, and particularly relates to an adamantane derivative as well as a synthesis method and application thereof. The adamantane derivative comprises an intermediate structural formula I, an intermediate structural formula II and an intermediate structural formula III, and the structural general formula is as follows: Linker is substituted or unsubstituted C6-C10 aroyl, R1 is hydrogen or C1-C6 alkyl, R2 is hydrogen, C1-C6 alkyl or a nitrogen-containing or nitrogen-free structural fragment, or the integral structure of R1R2 is N-substituted heterocyclic pentyl or heterocyclic cyclohexyl. According to the adamantane derivative provided by the invention, an adamantane structure is combined with part of groups of OAB-14, and a parent nucleus structure is changed, so that the drug activity is improved. The invention also provides a synthesis method of the compound, the obtained compound is screened through cell viability research, and the compound has a potential synergistic effect in the aspects of preventing influenza and treating Alzheimer's disease.
Owner:SHANDONG XINHUA PHARMA CO LTD

Cationic conjugated polymer as well as preparation method and application thereof

The invention provides a cationic conjugated polymer as well as a preparation method and application thereof. The structural formula of the cationic conjugated polymer is shown in the specification. The preparation method comprises the following steps: reacting tris (4-bromophenyl) amine and N, N-dimethyl-4-(4, 4, 5, 5-tetramethyl-1, 3, 2-dioxaborolane-2-yl) aniline in an organic solvent under the action of a catalyst and an initiator to obtain a first intermediate; the cationic conjugated polymer is prepared from the first intermediate, the second intermediate and the third intermediate under the action of a catalyst and an initiator. The cationic conjugated polymer shows good photo-thermal and photodynamic performance under the irradiation of near-infrared light with the wavelength of 980 nm, so that the effect of inhibiting the growth of bacteria is realized. # imgabs0 #
Owner:NANJING NORMAL UNIVERSITY

Flame-retardant sponge material as well as preparation method and application thereof

ActiveCN119798962APhosphorous acidDimethyl methylphosphonate
The invention relates to the field of sponge materials, and provides a flame-retardant sponge material as well as a preparation method and application thereof. The flame-retardant flame-retardant coating is prepared from the following components: phosphorus-based flame retardant modified oxidized feather-shaped carbon nanotubes, phosphorus-containing diol modified silicon dioxide aerogel, polyurethane, aluminum hydroxide, ammonium tripolyphosphate, toluene diisocyanate, deionized water, cyclopentane, triethanolamine, dibutyltin dilaurate, epoxidized soybean oil, talcum powder, an antioxidant, a light stabilizer, pigment and antimony trioxide. The composite material is prepared from expanded graphite, a silicone oil surfactant, an isothiazolinone antibacterial agent and a phosphorus-based flame retardant modified oxidized feather-shaped carbon nanotube through wet oxidation and dimethyl methylphosphonate modification, and phosphorus-containing diol is prepared from diethyl phosphite, diethanol amine and paraformaldehyde through condensation. The sponge disclosed by the invention has excellent mechanical and flame-retardant properties, and is widely applied to the fields of buildings, home furnishing and transportation.
Owner:NANTONG FENGSHENG TEXTILE CO LTD

Krypton gas separation compound as well as preparation method and application thereof

The invention belongs to the field of preparation of gas adsorption metal organic framework compounds, and discloses a krypton gas separation compound as well as a preparation method and application thereof. According to the invention, 1, 2-bis [2-methyl-3-thienyl-5-pyridine] perfluorocyclopentane is adopted to form the rigid metal organic framework material for the first time, and the rigid metal organic framework material is used as a stationary phase to be applied to gas adsorption and separation processes. According to the preparation method, expensive gas separation equipment does not need to be used, separation conditions are simple and convenient, meanwhile, pure and stable gas can be obtained, and the gas yield is high. The krypton gas separation compound prepared by the method is high in yield and purity, has good thermal stability, adsorbability and separation performance, and can be widely applied to separation and purification of industrial gas rich in krypton gas and nuclear waste gas.
Owner:JIANGXI SCI & TECH NORMAL UNIV

Construction and application of diosgenin and polyphyllin II synthetic strain

The invention discloses a series of recombinant bacteria for expressing a steroid compound taking a cyclopentane multi-hydrogen phenanthrene structure as a structural mother nucleus, such as recombinant strains for expressing cholesterol, 22-hydroxycholesterol, diosgenin or polyphyllin II, and construction and application of the strains. The invention provides a recombinant bacterium which can efficiently express a steroid compound taking cyclopentane multi-hydrogen phenanthrene as a structural mother nucleus, for example, the yield of diosgenin can be increased to the level of 40 mg / L or above, heterologous synthesis of the polyphyllin II is also realized to obtain a polyphyllin II synthetic strain, the yield of the polyphyllin II in a shake flask reaches 0.13 mg / L, and the yield of the polyphyllin II in the shake flask reaches 0.13 mg / L. The strain is the first strain for heterologous synthesis of the polyphyllin II at present.
Owner:CAPITAL UNIVERSITY OF MEDICAL SCIENCES

Memantine derivative as well as synthesis method and application thereof

The invention belongs to the technical field of medicine synthesis, and particularly relates to a memantine derivative and a synthesis method and application thereof. The memantine derivative comprises an intermediate structural formula I, an intermediate structural formula II, an intermediate structural formula III and a structural general formula, Linker is substituted or unsubstituted C6-C10 aroyl, R1 is hydrogen or C1-C6 alkyl, R2 is hydrogen, C1-C6 alkyl or a nitrogen-containing or nitrogen-free structural fragment, or the integral structure of R1 and R2 is N-substituted heterocyclic pentyl or heterocyclic cyclohexyl. According to the memantine derivative provided by the invention, a memantine group is combined with an OAB-14 partial structure to change a parent nucleus structure, so that the drug activity is improved. The invention also provides a synthesis method of the compound, and the obtained compound is used for treating Alzheimer's disease and Parkinson's disease.
Owner:SHANDONG XINHUA PHARMA CO LTD

Method for synthesizing cyclopentane compound through bromine ion / visible light concerted catalysis

The invention relates to the technical field of organic synthesis, in particular to a method for synthesizing cyclopentane compounds through [3 + 2] cycloaddition reaction of aryl cyclopropane and olefin under the synergistic catalysis of bromide ions / visible light. The method comprises the following steps: in a nitrogen atmosphere, sequentially adding aryl cyclopropane, a benzyl malononitrile derivative, pyridine tribromide and a photocatalyst into a reaction solvent to obtain a mixture, stirring the mixture at the temperature of 40 DEG C under the irradiation of a 12W blue light LED lamp until the reaction is complete, and performing concentration and column chromatography purification to obtain the cyclopentane compound. The method has the advantages of mild reaction conditions, simple operation, simple and easily available raw materials and low cost.
Owner:NANJING TECH UNIV

A system for integrated acetaldehyde distillation recovery and a method thereof

PendingCN122624913APtru catalystMeth-
The application provides a system and method for integrated acetaldehyde distillation and recovery, which comprises a vertically arranged main tower, the main tower is sequentially divided into a distillation section, a catalytic reaction section, a stripping section and a stripping section from top to bottom, the top of the distillation section is provided with a self-adaptive distributor and a tower top pressure controller, the catalytic reaction section comprises catalytic filler plates and a transverse liquid redistributor, and the catalytic filler plates are loaded with catalysts. The four sections of stripping, stripping, catalytic reaction and distillation are integrated in the vertical main tower, the intermediate cooling and conveying equipment are cancelled, and the investment and energy consumption are significantly reduced. The catalytic reaction section adopts the corrugated filler loaded with catalysts and cooperates with the transverse liquid redistributor, so that the liquid forms thin layer flow, the reaction residence time is effectively prolonged, and the hydrolysis decomposition rate of 2-methyl-1,3-dioxolane (MD) and the acetaldehyde recovery rate are improved.
Owner:SHAOXING CHITULONG MASCH TECH CO LTD

Cycloalkane separation method, computer program product and cycloalkane detection system

The invention provides a cycloalkane separation method, a computer program product and a cycloalkane detection system. The method comprises the steps that a detection device is controlled to separate compounds, the one-dimensional retention time of all the compounds in a one-dimensional chromatographic column is obtained, the two-dimensional retention time of all the compounds in a two-dimensional chromatographic column is obtained, the one-dimensional retention time is the time needed for separating out the compounds through the one-dimensional chromatographic column, and the two-dimensional retention time is the time needed for separating out the compounds through the two-dimensional chromatographic column. The two-dimensional retention time is the time required for separating the compound by the two-dimensional chromatographic column; a target compound in the separated compounds is determined according to the one-dimensional retention time and the two-dimensional retention time of the separated compounds, and the target compound is cyclohexane or cyclopentane; the content of the target compound is obtained, the content is sent to target equipment, and the target equipment is equipment used by the target object, so that the target object is guided to improve the catalyst. According to the scheme, the problem that cycloalkanes (cyclohexane or cyclopentane) cannot be rapidly measured in the prior art is solved.
Owner:CHINA SHENHUA COAL TO LIQUID & CHEM CO LTD +1

Medicinal salt of quinoline amine compound, crystal form and preparation method of medicinal salt

The invention relates to a pharmaceutical salt of a quinoline amine compound, a crystal form and a preparation method of the pharmaceutical salt. Specifically, the invention provides a pharmaceutically acceptable salt of 8-chloro-N-(2, 2-difluorobenzo [d] [1, 3] dioxacyclopentane-5-yl) quinoline-2-amine, a crystal form and a preparation method thereof, and the corresponding salt has good stability and can be better used for clinical treatment.
Owner:JIANGSU HENGRUI MEDICINE CO LTD +1

A production process, device and method of cyclopentanol

The present application includes a production process, device and method of cyclopentanol. The process includes pyrolyzing a raw material containing dicyclopentadiene to obtain a material A containing cyclopentadiene, mixing it with hydrogen and contacting it with a bimetallic catalyst to undergo a hydrogenation reaction to obtain a material B containing cyclopentene, cyclopentadiene and cyclopentane, mixing it with an acid and a solid acid catalyst to undergo a catalytic esterification reaction to obtain a material C containing fatty acid cyclopentyl ester and fatty acid cyclopentenyl ester, and mixing the material C with hydrogen and then mixing it with a copper-based hydrogenation catalyst to undergo a hydrogenation reaction to obtain a product containing cyclopentanol. The device includes a pyrolysis unit, a selective hydrogenation unit, a catalytic distillation unit and a catalytic hydrogenation unit connected in series in a pipeline; the route has low raw material cost, mild reaction conditions, simple operation, low separation energy consumption, and is suitable for continuous and stable large-scale production. Adding an inhibitor prolongs the life of the catalyst and improves the yield. The yield of cyclopentanol is more than 95% based on cyclic olefins as raw materials.
Owner:DALIAN INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES

Quinoline amine compound crystal form and preparation method thereof

The invention relates to a quinoline amine compound crystal form and a preparation method thereof. Specifically, the invention provides a crystal form of 8-chloro-N-(2, 2-difluorobenzo [d] [1, 3] dioxacyclopentane-5-yl) quinoline-2-amine and a preparation method thereof, and the corresponding crystal form has good stability and can be better used for clinical treatment.
Owner:JIANGSU HENGRUI MEDICINE CO LTD +1

Composite foaming agent, rigid polyurethane foam, preparation method and application

PendingCN121226829APolymer scienceFoaming agent
The invention discloses a composite foaming agent, rigid polyurethane foam, a preparation method and application, and belongs to the technical field of rigid polyurethane materials. According to the technical scheme, the foaming agent comprises a first physical foaming agent, a second physical foaming agent, a chemical foaming agent and silanized cellulose nanocrystals, the first physical foaming agent is cyclopentane, the second physical foaming agent is a low-boiling-point foaming agent, and the chemical foaming agent comprises an organic amine salt compound. The foaming agent is applied to thermal insulation materials, and the problem that an existing foaming agent system cannot give consideration to heat conduction and foam strength well is solved.
Owner:HISENSE RONSHEN GUANGDONG REFRIGERATOR

A process for the preparation of baricitinib

ActiveCN117720543BPtru catalystBoronic acid
The application discloses a preparation method of baricitinib, and belongs to the technical field of drug synthesis. The method comprises the following steps: firstly, 2-[1-(ethylsulfonyl)-3-azetidinyl]acetonitrile and 4-pyrazole boron pinacol ester are subjected to a Michael addition reaction to obtain 1-(ethylsulfonyl)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]-3-azetidine acetonitrile as an intermediate I; secondly, a protection group is introduced on the amino group of 4-chloropyrrolopyrimidine to obtain an intermediate II; finally, the intermediate I and the intermediate II are subjected to a Suzuki coupling process by adopting a method of combining a nickel pre-catalyst with a supporting ligand to obtain the baricitinib. The preparation method creatively realizes cross coupling of the baricitinib by adopting the cheap metal nickel as a catalyst, avoids the use of a heavy metal palladium catalyst, and has the advantages of low cost, low toxicity, small pollution, green environmental protection and the like.
Owner:NORTHEAST FORESTRY UNIV

Crystal form VI of acrylamide compound as well as preparation method and application of crystal form VI

The invention provides a crystal form VI of an acrylamide compound, and the acrylamide compound is (S)-N-(5-((6-(2-(7, 7-dimethyl-1-oxo-1, 3, 4, 6, 7, 8-hexahydro-2H-cyclopentane [4, 5] pyrrolo [1, 2-a] pyrazine-2-yl)-3-(hydroxymethyl) pyridine-4-yl)-4-methyl-3-oxo-3, 3, 4-triazolo [1, 2-a] pyrazine-2-yl)-3-(hydroxymethyl) pyridine-4-yl)-4-methyl-3-oxo-3, 3, 4-triazolo [1, 2-a] pyrazine-2-yl)-3-(2, 3, 4-triazolo [1, 2-a] pyrazine-2-yl)-4- The crystal form VI is a 2-(2, 4-dihydropyrazine-2-yl) amino)-2-(2-methyl-4-(tetrahydro-2H-pyran-4-yl) piperazine-1-yl) 5phenyl) acrylamide compound, and an X-ray powder diffraction pattern of the crystal form VI comprises diffraction peaks with the following 2 theta angle values: 8-3 + / -0.2 degrees, 13.2 + / -0.2 degrees and 18.9 + / -0.2 degrees. The crystal form VI has the advantages of good stability and low hygroscopicity, and is suitable for industrial production of bulk drugs and development of preparation prescriptions.
Owner:GUANGZHOU LUPENG PHARMACEUTICAL COMPANY LTD

Lipoic acid derivative-based lipid compound, carrier and preparation method and application of nanoparticle composition entrapping nucleic acid medicine

The invention provides a preparation method and application of lipid nanoparticles based on lipoic acid derivatives. The lipoic acid derivative provided by the invention depends on a cyclopentane structure and a disulfide bond of lipoic acid, so that a lipid compound is more easily internalized by cells, and the effectiveness of nucleic acid delivery is improved. The lipid nanoparticles have excellent spleen targeting performance, and drugs are preferentially delivered to the spleen.
Owner:HENAN UNIVERSITY

Azeotropic and azeotrope-like compositions comprising 1,2-dichloroethylene and 1h,2h-octafluorocyclopentane and use of the compositions as flash spinning agents

The present invention relates to (i) an azeotropic or azeotrope-like composition comprising (a) cis-1,2-dichloroethylene and cis-1H,2H-octafluorocyclopentane or comprising (b) trans-1,2-dichloroethylene and trans-1H,2H-octafluorocyclopentane, (ii) a spin fluid for flash spinning comprising these azeotropic or azeotrope-like compositions and a polyolefin, and (iii) a process for the preparation of plexifilamentary fibrils of polyolefin using the spin fluid.
Owner:DUPONT SAFETY & CONSTRUCTION INC

Use of (1s,3s)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (s)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere’s disease, tourette’s syndrome, attention deficit hyperactivity disorder and addiction

Methods of treating tinnitus, acute sensorineural hearing loss, Meniere's disease, Tourette's syndrome, ADHD or addiction with (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid or a pharmaceutically acceptable salt thereof are provided. Methods of treating tinnitus, acute sensorineural hearing loss, Meniere's disease, Tourette's syndrome, ADHD or addiction with (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid are provided. Also provided are therapeutic compositions that may be used to improve one or more symptoms of tinnitus, acute sensorineural hearing loss, Meniere's disease, Tourette's syndrome, ADHD or addiction.
Owner:OVID THERAPEUTICS INC

Preparation process of 5-ethylidene-2-norbornene

A preparation process of 5-ethylidene-2-norbornene, including: introducing dicyclopentadiene into a dicyclopentadiene decomposition reactor to thermally decompose the dicyclopentadiene; introducing a product of the above step into a cyclopentadiene purification tower; introducing 1,3-butadiene, a solvent, and cyclopentadiene separated from the top of the cyclopentadiene purification tower into a Diels-Alder reactor to react the same; introducing a product of the immediate above step into a 1,3-butadiene removal tower to recover 1,3-butadiene from the top; introducing a mixture at the bottom of the 1,3-butadiene removal tower into a desolvation tower, and recycling a solvent and unreacted raw materials recovered from the top of the desolvation tower to the dicyclopentadiene decomposition reactor; introducing a mixture at the bottom of the desolvation tower into a 5-vinyl-2-norbornene separation tower to separate 5-vinyl-2-norbornene; and introducing the 5-vinyl-2-norbornene into an isomerization reactor to react the same.
Owner:KOREA KUMHO PETROCHEMICAL CO LTD

High-toughness pet foamed sheet and method for manufacturing the same

PendingCN122255671AFiberPolymer science
This invention discloses a high-strength and tough PET foam sheet and its preparation method, belonging to the field of foam material technology. It comprises the following raw materials in parts by weight: 100 parts food-grade PET resin, 3-7 parts melt reinforcing agent, 3-5 parts crystallization toughening agent, 1-3 parts in-situ fiber-forming reinforcing agent, 1-5 parts compatibility dispersant, and 8-10 parts cyclopentane. The preparation method includes: S1, mixing dried food-grade PET resin with melt reinforcing agent, crystallization toughening agent, in-situ fiber-forming reinforcing agent, and compatibility dispersant to obtain a premix; S2, melting and plasticizing the premix, injecting liquid cyclopentane for blending, and then extruding to a normal pressure environment to obtain a foam sheet blank; S3, cooling and shaping the foam sheet blank, drawing, trimming, and winding to obtain a high-strength and tough PET foam sheet. The foam sheet obtained by this invention has fine and uniform pores, possessing high flexural strength, high modulus, and high impact toughness, with comprehensive performance far exceeding that of traditional PET foam materials.
Owner:ANHUI LESUI NEW MATERIAL CO LTD

Diamine cyclopentane compound, composition and application thereof

The invention discloses a diamine cyclopentane compound, a composition and application of the diamine cyclopentane compound, and belongs to the field of chemical medicines. The invention provides a diamine cyclopentane compound as shown in formula (I), or a pharmaceutically acceptable salt, a prodrug, a hydrate or a solvent compound, a crystal form, a stereoisomer or an isotope variant thereof, and the diamine cyclopentane compound can be used for preventing and inhibiting neurogenic inflammation, and is used for treating and / or preventing urticaria itching, angioedema and other related diseases. # imgabs0 #
Owner:YANCHENG ZHENGCHI BIOTECHNOLOGY CO LTD

Methyl 5-(methoxycarbonyl)-2-oxy-1, 3-dioxacyclopentane-4-formate and preparation method of methyl 5-(methoxycarbonyl)-2-oxy-1, 3-dioxacyclopentane-4-formate

The preparation method comprises the following steps: 1, adding tartaric acid, an acid-binding agent and a first organic solvent into a reaction container, uniformly mixing, cooling, dropwise adding a mixed solution of triphosgene and the first solvent into the reaction container under the condition that the temperature does not exceed 10 DEG C, and reacting for 1-2 hours at the temperature of 20-30 DEG C, so as to obtain 5-(methoxycarbonyl)-2-oxo-1, 3-dioxolane-4-methyl formate, namely the 5-(methoxycarbonyl)-2-oxo-1, 3-dioxolane-4-methyl formate, namely the 5-(methoxycarbonyl)-2-oxo-1, 3-dioxolane-4-methyl formate. After dropwise adding, heating to room temperature, stirring, and concentrating filtrate to obtain an intermediate; and 2, adding the intermediate, a second organic solvent, a catalyst and methanol into a reflux reaction container with a water knockout drum and a condenser, carrying out heating reflux reaction to separate water, concentrating the reaction liquid after the reaction is finished to obtain a crude product, adding the crude product into a first organic solvent, carrying out heating reflux, filtering to remove insoluble substances while the crude product is hot, cooling and crystallizing the filtrate, carrying out suction filtration, and drying to obtain the target product. The method has the advantages that the synthesis method is simple and easy to implement, the post-treatment method is easy to operate, and the product is high in purity and good in yield.
Owner:NINGDE GUOTAI HUARONG NEW MATERIAL CO LTD